Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 13, 2025
Entered into an Agreement to be acquired by QOL Medical
Net product sales for the third quarter of 2025 reached $4.3 million; up 61% year-over-year
Read more at globenewswire.comNASDAQ:EVOK (11/26/2025, 8:00:01 PM)
10.84
+0.04 (+0.37%)
Find more stocks in the Stock Screener
